new bull market sector biotech
As I have been saying for a month as golds and oils consolidate their huge gains over the last 2 years, I have been liquidating my gold and oil triples and redirecting funds into early bull market biotechs which work well in current slowing growrth environment. Best pick is SIRTEX Medical or SRX which will be announcing a whole bunch of good developments when DR Gray returns from ASCO in Atlanta. He owns 40 million of his net worth in shares and he wants higher than the $5 dollar bid from Cephalon 3 years ago now that the co is growing over 150% and profitable and Australia recently approved reimbursemnet in addition to USA where they get $15000 for each treatment. Expecting big gap up soon and $5-6 short term. Cheers
